A new perspective on the nitrate–phosphodiesterase type 5 inhibitor interaction
RA Kloner, P Goggin, I Goldstein… - Journal of …, 2018 - journals.sagepub.com
Background: Nitrates and nitrate-containing compounds are vasodilators used for the
treatment of angina and heart failure. Phosphodiesterase type 5 inhibitors used for the …
treatment of angina and heart failure. Phosphodiesterase type 5 inhibitors used for the …
[引用][C] Ion channels in genetic epilepsy: from genes and mechanisms to disease-targeted therapies
[PDF][PDF] 灯盏生脉胶囊联合单硝酸异山梨酯缓释片对老年冠心病心绞痛患者心功能, 血脂及血清IL-6
郭红玲， 欧阳艳红， 王圣， 黄咏东… - CRP 水平的影响, 2021 - biomed.cnjournals.com
摘要目的: 观察单硝酸异山梨酯缓释片联合灯盏生脉胶囊对老年冠心病心绞痛患者血脂,
心功能及血清C 反应蛋白(CRP), 白介素-6 (IL-6) 水平的影响. 方法: 选择2018 年3 月至2020 …
心功能及血清C 反应蛋白(CRP), 白介素-6 (IL-6) 水平的影响. 方法: 选择2018 年3 月至2020 …
The efficacy and safety of ivabradine hydrochloride in hemodialysis patients with chronic heart failure
S Kawasaki, Y Sakai, S Harasawa… - Therapeutic …, 2024 - Wiley Online Library
Introduction There is little evidence for ivabradine hydrochloride in patients undergoing
hemodialysis. Methods In this open‐label prospective interventional trial of hemodialysis …
hemodialysis. Methods In this open‐label prospective interventional trial of hemodialysis …
Expert consensus on ivabradine-based therapy for heart rate management in chronic coronary syndrome and heart failure with reduced ejection fraction in India
JC Mohan, I Sathyamurthy, M Panja… - Current Cardiology …, 2023 - benthamdirect.com
Heart rate is an important indicator of health and disease and the modulation of heart rate
can help to improve cardiovascular outcomes. Besides β-blockers, Ivabradine is a …
can help to improve cardiovascular outcomes. Besides β-blockers, Ivabradine is a …
To stent or not to stent? Treating angina after ISCHEMIA—introduction
BJ Gersh, WE Boden, DL Bhatt, PH Stone… - European Heart …, 2021 - academic.oup.com
Whether percutaneous coronary intervention (PCI) when added to optimal medical therapy
(OMT) improves clinical outcomes in patients with chronic coronary syndromes (CCS) has …
(OMT) improves clinical outcomes in patients with chronic coronary syndromes (CCS) has …
[HTML][HTML] The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension
S Yamaguchi, N Nadoyama, K Kinjo, N Yagi, H Ishimori… - Cureus, 2023 - ncbi.nlm.nih.gov
Depressed cardiac systolic function in hemodialysis patients occurs for a variety of reasons
and is a clinical problem. Beta-blockers are a key drug in the treatment of heart failure; …
and is a clinical problem. Beta-blockers are a key drug in the treatment of heart failure; …
Insights into the mode of action of antianginal and vasodilating agents
S Patra, P Gupta, R Kumari, S Jana, PK Haldar… - How Synthetic Drugs …, 2023 - Elsevier
Angina pectoris is a clinical condition that develops from coronary atherosclerotic heart
disease. The therapeutic goal to treat angina is primarily based on enhancing myocardial …
disease. The therapeutic goal to treat angina is primarily based on enhancing myocardial …
STAVOVI STUDENATA RADIOLOŠKE TEHNOLOGIJE O ULOZI RADIOLOŠKOG TEHNOLOGA U TIMU ZA IZVOĐENJE PERKUTANE KORONARNE INTERVENCIJE
B Pavić - 2024 - repository.fzsri.uniri.hr
Sažetak Ishemijska bolest srca (IBS) jedan je od glavnih uzroka smrtnosti u Hrvatskoj.
Značajan napredak u njezinu liječenju donijela je perkutana koronarna intervencija (PCI) …
Značajan napredak u njezinu liječenju donijela je perkutana koronarna intervencija (PCI) …
Palmitoylation and regulation of the funny current HCN4 channel
SD Congreve - 2023 - theses.gla.ac.uk
The sinoatrial node (SAN) acts as the primary pacemaker of the heart as it spontaneously
generates electrical activity that propagate through the cardiac conduction system …
generates electrical activity that propagate through the cardiac conduction system …